financetom
Business
financetom
/
Business
/
Fabrinet Fiscal Q1 Non-GAAP Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fabrinet Fiscal Q1 Non-GAAP Earnings, Revenue Rise
Nov 4, 2024 2:32 PM

05:04 PM EST, 11/04/2024 (MT Newswires) -- Fabrinet ( FN ) reported fiscal Q1 non-GAAP diluted earnings late Monday of $2.39, up from $2.00 a year earlier.

Analysts surveyed by Capital IQ expected $2.38.

Revenue for the quarter ended Sept. 27 was $804.2 million, up from $685.5 million a year earlier.

Analysts polled by Capital IQ expected $771.1 million.

The company said it expects fiscal Q2 non-GAAP diluted earnings of $2.44 to $2.52. Analysts surveyed by Capital IQ expect $2.45.

Fabrinet ( FN ) expects revenue for the quarter of $800 million to $820 million. Analysts polled by Capital IQ expect $797.7 million.

Price: 243.72, Change: +0.70, Percent Change: +0.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nokia Enters Four-Year Deal Extension With Orange France
Nokia Enters Four-Year Deal Extension With Orange France
Feb 5, 2025
03:43 AM EST, 02/05/2025 (MT Newswires) -- Nokia ( NOK ) said Wednesday it has extended its partnership with Orange France with a new four-year contract to upgrade the latter's 5G radio infrastructure with Nokia's ( NOK ) AirScale portfolio. Financial terms were not disclosed. Orange will also test Nokia's ( NOK ) 5G cloud RAN offerings, the company said,...
Novo Nordisk's new CagriSema study to focus on dose escalation and trial length
Novo Nordisk's new CagriSema study to focus on dose escalation and trial length
Feb 5, 2025
COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk on Wednesday said its new trial of its next-generation obesity drug candidate CagriSema will look at dose escalation and trial length to further show the drug's potential, after data last month disappointed the market. CEO Lars Fruergaard Jorgensen told journalists on a media call that the company is confident in the drug's biology...
TotalEnergies CEO says Europe should negotiate with U.S. for free trade of LNG
TotalEnergies CEO says Europe should negotiate with U.S. for free trade of LNG
Feb 5, 2025
PARIS, Feb 5 (Reuters) - TotalEnergies CEO Patrick Pouyanne said on Wednesday that European countries should negotiate to obtain a guarantee of free exchange on LNG from the United States. Speaking to reporters after the company announced fourth quarter earnings, he added that all exports of LNG from the United States should practically double in 2025. ...
Italy's Fincantieri gets Norwegian Line cruise ship order worth $9 billion
Italy's Fincantieri gets Norwegian Line cruise ship order worth $9 billion
Feb 5, 2025
ROME, Feb 5 (Reuters) - Norwegian Line Holdings (NCL) and Italian shipbuilder Fincantieri said on Wednesday they had agreed a deal for four new cruise liners, which a source close to the matter said was worth around 9 billion euros ($9.34 billion). Fincantieri has already built two ships for NCL and a third, called the Norwegian Aqua, will be delivered...
Copyright 2023-2026 - www.financetom.com All Rights Reserved